Stocklytics Platform
Asset logo for symbol REGN
Regeneron Pharmaceuticals
REGN68
$1,078.63arrow_drop_up1.35%$14.44
S&P500
Asset logo for symbol REGN
REGN68

$1,078.63

arrow_drop_up1.35%

AI Deep-Learning Forecast (REGN)

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Regeneron Pharmaceuticals (REGN) Stocklytics Forecast

Regeneron Pharmaceuticals Inc (REGN) is a leading biotechnology company focused on the discovery, development, and commercialization of innovative medicines for the treatment of serious diseases. With a strong track record of scientific excellence and a robust pipeline of promising drug candidates, REGN has positioned itself as a key player in the pharmaceutical industry.
The stock price of REGN has been on an upward trajectory in recent years, driven by the company's impressive financial performance and positive market outlook. Analysts expect the stock price to continue its upward trend in the coming years, with a forecasted price target of $600 by 2023. This bullish outlook is supported by REGN's solid revenue growth, driven by strong sales of its flagship products like Eylea and Dupixent.
add Regeneron Pharmaceuticals to watchlist

Keep an eye on Regeneron Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the analyst price prediction for Regeneron Pharmaceuticals (REGN) stock?
Analysts have set a target price of $956.76 for Regeneron Pharmaceuticals (REGN), based on forecasts from 29 analysts. The predicted price range extends from a high of $1.11K to a low of $800. This represents a potential increase of up to 2.91% and a decrease of -25.83% from the current price of $1.08K. These forecasts are as of 2023 Aug 21.
help
What are the analyst ratings for Regeneron Pharmaceuticals (REGN) stock?
Currently, there are no analyst ratings available for Regeneron Pharmaceuticals (REGN), possibly due to insufficient coverage or recent updates.
help
What is the AI price prediction for Regeneron Pharmaceuticals (REGN) stock?
At present, there is no AI or machine-learning-based price prediction available for Regeneron Pharmaceuticals (REGN) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.
email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level